
Photo taken from: Rami Manochakian / Twitter
Jul 10, 2023, 03:08
Study showed better OS & quality of life with Atezo – Rami Manochakian, MD
Hot off the press @TheLancet IPSOS phase 3 trial of 1st line Atezolizumab monotherapy vs single-agent chemotherapy in pts with advanced NSCLC ineligible for a platinum-containing chemo. Study showed better OS & quality of life with Atezo.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 24, 2025, 19:21
Mar 24, 2025, 18:21
Mar 24, 2025, 18:12
Mar 24, 2025, 18:06